Profitability
Weight: 25%
A-
87
- 5yr Avg ROIC 15.5%
- Operating Margin Trend +2.66 pp/yr
UTHR
United Therapeutics Corporation
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
B-
68
- 5yr Avg ROE 16.2%
- 5yr Share-Count CAGR 1.4%
Growth Quality
Weight: 25%
A+
95
- 5yr Revenue CAGR 16.5%
- 5yr EPS CAGR 19.3%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
A+
94
- 5yr FCF Margin 33.0%
- 5yr FCF/NI Conversion 0.87x
Balance Sheet
Weight: 10%
A+
100
- Net Debt / EBITDA -0.84x
- Interest Coverage (EBIT/Int) 88.89x
- Altman Z-Score 20.63
Stability
Weight: 5%
B-
68
- EPS Volatility (σ/μ) 0.39
- Negative-Revenue Years (5) 0/5
- Piotroski F-Score 7
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.3 of 4 gurus held; 2 added; 1 trimmed; 1 full exit.
- Holders
- 3 -1
- Avg Δ position
- +598.8%
- New buys
- 0
- Full exits
- 1
- Cooperman sold -100%
- Wood increased +1798%
- Greenblatt decreased -2%